DOI QR코드

DOI QR Code

Induction of anti-aquaporin 5 autoantibodies by molecular mimicry in mice

  • Lee, Ahreum (Department of Immunology and Molecular Microbiology, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Choi, Youngnim (Department of Immunology and Molecular Microbiology, School of Dentistry and Dental Research Institute, Seoul National University)
  • Received : 2020.08.03
  • Accepted : 2020.10.15
  • Published : 2020.12.31

Abstract

Molecular mimicry is the most common mechanism that breaches self-tolerance. We previously identified autoantibodies to aquaporin-5 (AQP5) in the sera of patients with Sjögren's syndrome and found that the aquaporin of Prevotella melaninogenica (PmAqp), an oral commensal, is highly homologous to human AQP5. This study aimed to test whether PmAqp can induce anti-AQP5 autoantibodies via molecular mimicry. From the amino acid sequence of PmAqp, an immunizing peptide; i.e., PmE-L, was designed, which contained both the B cell epitope "E" and T cell epitope. C57BL/6 and BALB/c mice were subcutaneously immunized with linear or cyclic forms of PmE-L emulsified in incomplete Freund's adjuvant. The concentrations of the antibodies in sera were measured using enzyme-linked immunosorbent assays. Both linear and cyclic PmE-L induced high levels of antibodies against not only the immunized peptides but also autoantibodies against AQP5E and antibodies against PmE, a Pm homolog of AQP5E. In C57BL/6 mice; however, the cyclic form of PmE-L was more efficient than the linear form in inducing autoantibodies against AQP5E that contained a cyclic epitope. The levels of anti-PmE antibodies and anti-AQP5E autoantibodies showed a strong positive correlation (r = 0.95, p < 0.0005), suggesting molecular mimicry. Collectively, the mice produced anti-AQP5E autoantibodies in response to a PmAqp-derived peptide. This model proved to be useful for studying the mechanisms of autoantibody production by molecular mimicry.

Keywords

References

  1. Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005;435:590-7. doi: 10.1038/nature03724.
  2. Christen U. Pathogen infection and autoimmune disease. Clin Exp Immunol 2019;195:10-4. doi: 10.1111/cei.13239.
  3. Sinha AA, Lopez MT, McDevitt HO. Autoimmune diseases: the failure of self tolerance. Science 1990;248:1380-8. doi: 10.1126/science.1972595.
  4. Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol 2012;42:102-11. doi: 10.1007/s12016-011-8294-7.
  5. Ben-Chetrit E, Fischel R, Rubinow A. Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome. Clin Rheumatol 1993;12:471-4. doi: 10.1007/BF02231773.
  6. Daniels TE, Cox D, Shiboski CH, Schiodt M, Wu A, Lanfranchi H, Umehara H, Zhao Y, Challacombe S, Lam MY, De Souza Y, Schiodt J, Holm H, Bisio PA, Gandolfo MS, Sawaki T, Li M, Zhang W, Varghese-Jacob B, Ibsen P, Keszler A, Kurose N, Nojima T, Odell E, Criswell LA, Jordan R, Greenspan JS. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjogren's syndrome among 1,726 registry participants. Arthritis Rheum 2011;63:2021-30. doi:10.1002/art.30381.
  7. Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J Autoimmun 2010;34:400-7. doi: 10.1016/j.jaut.2009.10.004.
  8. Nezos A, Mavragani CP. Contribution of genetic factors to Sjogren's syndrome and Sjogren's syndrome related lymphomagenesis. J Immunol Res 2015;2015:754825. doi: 10.1155/2015/754825.
  9. Imgenberg-Kreuz J, Rasmussen A, Sivils K, Nordmark G. Genetics and epigenetics in primary Sjogren's syndrome. Rheumatology (Oxford) 2019;key330. doi: 10.1093/rheumatology/key330.
  10. Routsias JG, Tzioufas AG. Sjogren's syndrome--study of autoantigens and autoantibodies. Clin Rev Allergy Immunol 2007;32:238-51. doi: 10.1007/s12016-007-8003-8.
  11. Lim YS, Yoo KY. Study on the changes in distributions and expressions of aquaporin5 (AQP5) in salivary glands of mice after alcohol ingestion. Int J Oral Biol 2018;43:185-91. doi: 10.11620/IJOB.2018.43.4.185.
  12. Alam J, Koh JH, Kwok SK, Park SH, Park K, Choi Y. Functional epitopes for anti-aquaporin 5 antibodies in Sjogren syndrome. J Dent Res 2017;96:1414-21. doi: 10.1177/0022034517717965.
  13. Alam J, Koh JH, Kim N, Kwok SK, Park SH, Song YW, Park K, Choi Y. Detection of autoantibodies against aquaporin-5 in the sera of patients with primary Sjogren's syndrome. Immunol Res 2016;64:848-56. doi: 10.1007/s12026-016-8786-x.
  14. Alam J, Lee A, Lee J, Kwon DI, Park HK, Park JH, Jeon S, Baek K, Lee J, Park SH, Choi Y. Dysbiotic oral microbiota and infected salivary glands in Sjogren's syndrome. PLoS One 2020;15:e0230667. doi: 10.1371/journal.pone.0230667.
  15. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011;29:621-63. doi: 10.1146/annurev-immunol-031210-101400.
  16. Barnett LG, Simkins HM, Barnett BE, Korn LL, Johnson AL, Wherry EJ, Wu GF, Laufer TM. B cell antigen presentation in the initiation of follicular helper T cell and germinal center differentiation. J Immunol 2014;192:3607-17. doi: 10.4049/jimmunol.1301284.
  17. Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998;281:96-9. doi: 10.1126/science.281.5373.96.
  18. Harding CV, Unanue ER. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 1990;346:574-6. doi: 10.1038/346574a0.
  19. Maslinska M. The role of Epstein-Barr virus infection in primary Sjogren's syndrome. Curr Opin Rheumatol 2019;31:475-83. doi: 10.1097/BOR.0000000000000622.
  20. Yeh CC, Wang WC, Wu CS, Sung FC, Su CT, Shieh YH, Chang SN, Su FH. Association of Sjogrens syndrome in patients with chronic hepatitis virus infection: a population-based analysis. PLoS One 2016;11:e0161958. doi: 10.1371/journal.pone.0161958.
  21. Mozdzanowska K, Zharikova D, Cudic M, Otvos L, Gerhard W. Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse. Virol J 2007;4:118. doi: 10.1186/1743-422X-4-118.
  22. Uddowla S, Freytag LC, Clements JD. Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens. Vaccine 2007;25:7984-93. doi: 10.1016/j.vaccine.2007.09.030.